NDA 21-567 Atazanavir
NDA 21-567 Atazanavir. Kendall A. Marcus, M.D. Medical Reviewer Division of Antiviral Drug Products. Presentation Outline. NDA Submission Overview Efficacy Summary - Tom Hammerstrom, Ph.D. Clinical Virology - Lisa Naeger, Ph.D. Safety Issues Hyperbilirubinemia Lipid Profiles
1.31k views • 107 slides